83.57-2.3 (-2.70%)
26 Aug, 12:00 AM

Annual Reports and Financial Documents

Bal Pharma Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.
20132014201520162017201820192020202120222023202420252026
Annual ReportsFY 2013FY 2014FY 2015FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Quarterly Results
Conference Calls
Presentations

Corporate Announcements and Regulatory Filings

Bal Pharma Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.
  1. Reg. 34 (1) Annual Report26 Aug 2026
    Reg. 34 (1) Annual Report.
    Bal Pharma Limited Annual Report 2026
  2. AGM26 Aug 2026
    Bal Pharma Limited - Notice Of AGM
    39th AGM of the Company Scheduled on 24th September 2026. Notice copy enclosed
  3. AGM26 Aug 2026
    Intimation - 39Th AGM Scheduled On 24Th September 2026
    This is to inform that 39th AGM of Bal Pharma Limited Scheduled to be held on Thursday 24th September 2026 at 11.00 AM through VC Mode.
  4. General25 Aug 2026
    Clarification With Respect To Tentative Timeline For Utilization Of Net Proceeds Of Preferential Issue
    This is in Continuation of Company earlier intimation made in connection with allotment of warrants , hereby clarify that utilization of net proceeds or tenure of warrants is 18 month from ....
  5. General13 Aug 2026
    Newspaper Publications - Unaudited Financial Results 30Th June 2026 And IEPF Notice
    In Continuation of Outcome of Board meeting dated August 12 2026 , Published Unaudited Financial result for the quarter ended 30th June 2026 and IEPF Notice in Financial express and Sanjevani ....
  6. Outcome of Board Meeting12 Aug 2026
    Board Meeting Outcome for Outcome Of Board Meeting Held On Wednesday, August 12 2026
    Board of directors of the Company met on Wednesday, August 12 2026 inter alia transacted the following business. 1. Considered and approved the unaudited Financial Results (Standalone ....
  7. Postal Ballot10 Aug 2026
    Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
    Scrutinizers Report Pertaining to Postal Ballot Notice dated July 09 2026 read with its Corrigendum dated July 23rd 2026.
  8. Postal Ballot10 Aug 2026
    Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot
    Outcome : Result of Postal Ballot Notice dated July 09 2026 read with its Corrigendum dated July 23 , 2026
  9. Board Meeting5 Aug 2026
    Board Meeting Intimation for Considering Inter-Alia The Unaudited (Standalone And Consolidated) Financial Statements Of The Company For The First Quarter Ended 30Th June 2026 And Other General Business Matters
    Bal Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 ,inter alia, to consider and approve Pursuant to Regulation 29 and other ....
  10. General30 Jul 2026
    Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 : Intimation Regarding Notice Of Postal Ballot
    Company Providing opportunity to shareholders to Submit their Comments on Corrigendum to the Postal ballot notice
  11. General23 Jul 2026
    Intimation Regarding Corrigendum To The Postal Ballot Notice
    In Continuation of Postal Ballot Notice dated 09th July 2026 , Submitting Corrigendum as integral part to the Said Notice.
  12. Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 201813 Jul 2026
    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
    Certificate under Regulation 74(5) of SEBI (DP) Regulations for the quarter ended 30.06.2026
  13. Postal Ballot9 Jul 2026
    Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
    Postal Ballot Notice for consider the issue of 1000000 Warrants to Mr. Shailesh Siroya , promoter of the Company on preferential basis
  14. Appointment of Company Secretary / Compliance Officer24 Jun 2026
    Appointment of Company Secretary and Compliance Officer
    This is with reference to our earlier intimation dated 27th May 2026 regarding appointment of Mr. Shreepada ML as company secretary and compliance officer of the company pursuant to the ....
  15. Closure of Trading Window24 Jun 2026
    Closure of Trading Window
    Trading window closure for the quarter ended 30.06.2026.
  16. Newspaper Publication29 May 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    We are submitting the newspaper advertisements of the Audited financial results ( standalone & Consolidated ) for the quarter and financial year ended 31.03.2026 announced by the Company ....
  17. Reg. 32 (1), (3) - Statement of Deviation & Variation29 May 2026
    Non Applicability Of Statement Of Deviation & Variation
    Filing of Statement of deviation & variation is not applicable to the Company for the quarter ended 31.03.2026.
  18. Meeting Updates22 May 2026
    Announcement under Regulation 30 (LODR)-Meeting Updates
    In addition to the agenda items mentioned in our board meeting notice dated 18.05.2025, the following agenda item will also be considered at the meeting scheduled on 27.05.2026. 1. To ....
  19. Reg.24(A)-Annual Secretarial Compliance22 May 2026
    Compliances-Reg.24(A)-Annual Secretarial Compliance
    Annual Secretarial Compliance Report for the financial year ended 31.03.2026.
  20. Board Meeting18 May 2026
    Board Meeting Intimation for Intimation Of The Board Meeting
    Bal Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2026 ,inter alia, to consider and approve 1. Audited financial results of ....

Frequently Asked Questions

Where can I download the annual report of Bal Pharma Ltd.?
Annual reports of Bal Pharma Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.
Where can I find the quarterly results of Bal Pharma Ltd.?
Quarterly earnings results and presentations of Bal Pharma Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.
Does Bal Pharma Ltd. publish earnings call transcripts?
Earnings call transcripts of Bal Pharma Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.
Where can I find investor presentations of Bal Pharma Ltd.?
Investor presentations and annual day presentations of Bal Pharma Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.
What are the recent corporate announcements of Bal Pharma Ltd.?
Corporate announcements and regulatory filings of Bal Pharma Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.
How do I access the regulatory filings of Bal Pharma Ltd.?
Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Bal Pharma Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.
What is the ISIN of Bal Pharma Ltd.?
The ISIN (International Securities Identification Number) of Bal Pharma Ltd. is INE083D01012. This is the unique identifier used across exchanges and depositories.
On which stock exchange is Bal Pharma Ltd. listed?
Bal Pharma Ltd. is listed on NSE and BSE. The NSE symbol is BALPHARMA and the BSE code is -.
Where can I find the shareholding pattern of Bal Pharma Ltd.?
The quarterly shareholding pattern of Bal Pharma Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.
How current is the data for Bal Pharma Ltd. on Sharpely?
Share price data for Bal Pharma Ltd. is updated as of 26 Aug 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.